Medicine
Aucatzyl kit
Aucatzyl kit is a prescription medicine containing Obecabtagene autoleucel, marketed by Autolus, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Do not re-freeze after thawing. Store AUCATZYL frozen in the vapor phase of…
Key facts
- Active ingredient (INN)
- Obecabtagene autoleucel
- Brand
- Aucatzyl
- Dosage form
- Kit
- Packs
- 1 kit
- Marketing authorisation holder
- Autolus
- Manufacturer
- Autolus
- Origin register
- US FDA, United States
- Storage
- Do not re-freeze after thawing. Store AUCATZYL frozen in the vapor phase of liquid nitrogen (below minus 150°C).
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L01XL Cancer medicines (antineoplastics), subgroup L01X, subgroup L01XL
- HS code (indicative)
- 3002.51Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 8 November 2024
- Identifiers
- RxCUI 2700168, 2700173, 2700174 +1DailyMed set ID 4fef6986-b988-45e4-8c20-b14f0ef1f538NDC 83047-410Application BLA125813
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 kit in 1 package * 1 suspension in 1 bag * 1 suspension in 1 bag * 1 suspension in 1 bag * 1 suspension in 1 bag | 83047-410-04 | Autolus | 8 November 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Obecabtagene autoleucel is a prescription medicine indicated for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). It is available as kits. MedsAcross supplies Obecabtagene autoleucel for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Obecabtagene autoleucelFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- AUCATZYL prescribing information (Autolus) · U.S. National Library of Medicine, DailyMed
- Aucatzyl: European public assessment report (EPAR) · European Medicines Agency
Need Aucatzyl kit for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.